CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare ...

Please provide your email address to receive an email when new articles are posted on . Rocket Pharmaceuticals announced that the FDA has granted fast track and orphan drug designations to its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Both DSP cardiomyopathy and plakophilin 2 are associated with arrhythmogenic right ventricular ...

Tenaya Therapeutics has announced interim data from its RIDGE natural history study, the largest research effort to date on arrhythmogenic right ventricular cardiomyopathy (ARVC) associated with ...

Microscopy image showing heart muscle cells (gray) in a mouse heart. The plakophilin-2 protein (green) is present in the desmosomes connecting adjacent heart muscle cells. After introduction of the ...

Researchers from Osaka University find that patient-derived cardiomyocytes carrying a mutation associated with arrhythmogenic cardiomyopathy exhibit the decreased contraction and impaired desmosome ...